IIT-H, PharmCADD ink deal to co-develop new drugs
The Hindu
Agree to promote alliance in global R&D projects
Korean firm PharmCADD (AI and Physics/Quantum-based drug discovery company) has recently signed a Memorandum of Understanding (MoU) with the Indian Institute of Technology - Hyderabad (IITH), for co-developing new drugs and advancing platform technology PharmulatorTM. Under this MoU, IIT-H will provide PharmCADD key members to conduct academic research in the field of AI, MD simulation, and quantum calculation for new drug development. PharmCADD and IIT-H also agreed to promote collaboration by jointly participating in global R&D projects.More Related News